EFFECTS OF NIFEDIPINE SR AND ENALAPRIL ON OFFICE, HOME AND AMBULATORY BLOOD-PRESSURE IN WHITE-COAT SYSTEMIC HYPERTENSION

被引:18
作者
ASHIDA, T [1 ]
ABE, H [1 ]
KAWANO, Y [1 ]
YOSHIDA, K [1 ]
KIMURA, G [1 ]
KOJIMA, S [1 ]
YOSHIMI, H [1 ]
KAWAMURA, M [1 ]
IMANISHI, M [1 ]
SANAI, T [1 ]
KURAMOCHI, M [1 ]
OMAE, T [1 ]
机构
[1] NATL CARDIOVASC CTR,DEPT MED,DIV NEPHROL,SUITA,OSAKA 565,JAPAN
关键词
D O I
10.1016/0002-9149(90)90713-B
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Among patients who were found to have hypertension by office or clinic blood pressure (BP) measurement, some appear to be normotensive when studied for full 24-hour periods by ambulatory BP monitoring, indicating so-called "office" or "white-coat" hypertension. Within groups of hypertensive patients with similar office BPs, those with higher than predicted ambulatory BP have greater prevalence of target-organ damage1,2 and a significantly greater 10-year incidence of fatal and unfatal events than those with lower than predicted ambulatory BP.3 Moreover, there is some indication that reducing BP too much may exert a deleterious rather than a beneficial effect on coronary events.4 In the present study, we examined and compared the effects of the long-acting calcium antagonist nifedipine slow-release tablet (nifedipine SR) with the effects of the long-acting angiotensin converting enzyme inhibitor enalapril on office, home and ambulatory BP measurements. We studied hypertensive patients with relatively higher and relatively lower ambulatory BPs. © 1990.
引用
收藏
页码:498 / 501
页数:4
相关论文
共 12 条
[1]   HEMODYNAMIC EFFECTS OF A CALCIUM ANTAGONISTIC AGENT (NIFEDIPINE) IN HYPERTENSION - THERAPEUTIC IMPLICATIONS [J].
BARTORELLI, C ;
MAGRINI, F ;
MORUZZI, P ;
OLIVARI, MT ;
POLESE, A ;
FIORENTINI, C ;
GUAZZI, M .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 55 :S291-S292
[2]  
CRUICKSHANK JM, 1987, LANCET, V1, P581
[3]   NIFEDIPINE - INDIVIDUAL-RESPONSES AND CONCENTRATION-EFFECT RELATIONSHIPS [J].
DONNELLY, R ;
ELLIOTT, HL ;
MEREDITH, PA ;
KELMAN, AW ;
REID, JL .
HYPERTENSION, 1988, 12 (04) :443-449
[4]  
ERNE P, 1983, HYPERTENSION, V5, P97
[5]   AGE, RACE, BLOOD-PRESSURE AND RENIN - PREDICTORS FOR ANTIHYPERTENSIVE TREATMENT WITH CALCIUM-ANTAGONISTS [J].
KIOWSKI, W ;
BUHLER, FR ;
FADAYOMI, MO ;
ERNE, P ;
MULLER, FB ;
HULTHEN, UL ;
BOLLI, P .
AMERICAN JOURNAL OF CARDIOLOGY, 1985, 56 (16) :H81-H85
[6]  
KURIYAMA Y, 1989, SHOULD ELDERLY HYPER, P69
[7]  
MACGREGOR GA, 1982, J CARDIOVASC PHARM, V4, pS358
[8]   DOES THE RENIN-ANGIOTENSIN SYSTEM MAINTAIN BLOOD-PRESSURE IN BOTH HYPERTENSIVE AND NORMOTENSIVE SUBJECTS - COMPARISON OF PROPRANOLOL, SARALASIN AND CAPTOPRIL [J].
MACGREGOR, GA ;
MARKANDU, ND ;
ROULSTON, JE .
CLINICAL SCIENCE, 1979, 57 :S145-S148
[9]   THE PROGNOSTIC VALUE OF AMBULATORY BLOOD PRESSURES [J].
PERLOFF, D ;
SOKOLOW, M ;
COWAN, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (20) :2792-2798
[10]  
SOKOLOW M, 1966, CIRCULATION, V34, P279